Former Senior Vice President, Chief Medical Officer For Given Imaging
Life Science Partner recruited David Mason, MD to become Vice President, Medical Affairs and Clinical Programs at MiMedx Group, a premier global processor and distributer of human amniotic tissue grafts across multiple therapeutic areas. Mason joins the MiMedx team from his role at Given Imaging following its acquisition by Covidien earlier this year.
In his new role at MiMedx, Mason will lead the clinical direction and oversight of the company’s product development, research and regulatory compliance. “Mason has the ability and talent to add value to the launch process of small molecules and complex biologics across a range of therapeutic areas,” stated Tom Callaway, MD, Founder and President of Life Science Partner. “In this new role, Mason will oversee Mimedx’ relationship with the FDA and the regulation of these important, tissue-derived products.”
Mason earned his Bachelor of Arts in Chemistry from Williams College in Massachusetts and his MD from Duke University Medical School, North Carolina. Mason is board certified in Internal Medicine and previously specialized in infectious diseases and rheumatology in his private practice.